Farquhar John C.M. sold $643K of HTFL

Farquhar John C.M. (Chief Executive Officer) sold 22,562 shares of Heartflow, Inc. (HTFL) at $28.50 ($0.64M total) on 2026-06-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Farquhar John C.M.
Published Jun 12, 2026, 10:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 12, 2026, 10:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HTFL
Neutral
medium confidence
Mentioned
$HTFL
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HTFLNeutralLow
01

Why it matters

The disclosure updates the record of insider activity (CEO direct holdings reduced), but the pre-arranged 10b5-1 plan suggests the sale was scheduled rather than information-driven.

02

Market read

Traders may note insider selling, but the 10b5-1 framing makes it more of a sentiment datapoint than a catalyst.

03

What to watch

The article provides only the sale details; without concurrent buys, guidance changes, or operational updates, the trading signal is weak.

Relevance 4/10Novelty 8/10Timing: Filed 2026-06-12; sale executed 2026-06-10

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Heartflow, Inc.

Company-level read

Ticker impact

$HTFLNeutralMedium confidence
Context

Heartflow CEO John C.M. Farquhar sold 22,562 shares in an open-market transaction worth $643,017 under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be muted unless accompanied by other company-specific news.

Evidence & confidence

Form 4 insider sales are common and the filing specifies a pre-arranged 10b5-1 plan, reducing the signal of new information.

Market effects

No clear sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Insider selling under a 10b5-1 plan can be purely mechanical (tax/portfolio rebalancing) and may not reflect bearish expectations.

Key entities

  • Heartflow, Inc.

    Company whose CEO executed an open-market sale disclosed on SEC Form 4.

  • John C.M. Farquhar

    CEO and director who sold 22,562 shares on 2026-06-10.

  • 10b5-1 plan

    Pre-arranged plan cited in the filing, typically reducing interpretive signal.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

HeartFlow: 3 Key Takeaways for Long-Term Investors

HeartFlow reported revenue growth outpacing expenses, narrowing operating losses. The company has $253M in cash and expects to achieve positive cash flow by mid-2028. It aims for an 85% non-GAAP gross margin and is expanding its platform with new products like PCI Navigator. Management highlights structural advantages and growing clinical evidence.

$HTFLHighAI 8/10

HeartFlow (HTFL) Q3 2026 Earnings Call Transcript

HeartFlow (HTFL) reported Q3 2026 revenue of $72.9M, up 57% YoY, driven by Plaque adoption and FFRCT utilization. They raised full-year revenue guidance to $262M-$264M, up 49%-50% YoY. Non-GAAP gross margin guidance was increased to 82.5%, with midterm profitability goals reaffirmed. Commercial adoption and clinical evidence support growth.

$HTFLMedAI 8/10

What Heartflow (HTFL) Said on Its Q3 Earnings Call

Heartflow (HTFL) expects to reach cash flow profitability by mid-2028, with declining operating expenses and narrowing losses. The company anticipates 1,300 Plaque Analysis-activated accounts by year-end and 37% year-over-year FFRct volume growth in Q4. Plaque Analysis pricing is expected to be flat sequentially, with a 10% increase in Q1 2027. Clinical data shows Plaque Analysis reduces major cardiovascular events and heart attack rates.